TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,958,886 | +7.9% | 5,233,281 | +9.5% | 0.01% | +14.3% |
| Q2 2023 | $75,055,387 | -0.6% | 4,777,552 | +4.3% | 0.01% | -12.5% |
| Q1 2023 | $75,487,489 | +7.0% | 4,580,551 | +1.3% | 0.01% | 0.0% |
| Q4 2022 | $70,565,659 | +17.7% | 4,523,439 | -2.2% | 0.01% | 0.0% |
| Q3 2022 | $59,961,000 | +0.6% | 4,623,007 | +8.9% | 0.01% | 0.0% |
| Q2 2022 | $59,583,000 | +1187.7% | 4,243,825 | +1213.2% | 0.01% | +700.0% |
| Q1 2022 | $4,627,000 | -51.5% | 323,178 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $9,549,000 | -70.0% | 700,611 | -64.0% | 0.00% | -75.0% |
| Q3 2021 | $31,842,000 | -6.6% | 1,943,963 | -4.1% | 0.00% | 0.0% |
| Q2 2021 | $34,104,000 | -13.0% | 2,026,382 | -5.6% | 0.00% | -33.3% |
| Q1 2021 | $39,208,000 | +9.7% | 2,147,183 | +9.4% | 0.01% | 0.0% |
| Q4 2020 | $35,737,000 | -0.7% | 1,963,542 | -2.7% | 0.01% | -14.3% |
| Q3 2020 | $36,007,000 | +1.7% | 2,018,318 | +2.2% | 0.01% | -12.5% |
| Q2 2020 | $35,398,000 | +48.0% | 1,974,155 | +25.3% | 0.01% | +14.3% |
| Q1 2020 | $23,923,000 | +65.4% | 1,575,982 | +114.9% | 0.01% | +133.3% |
| Q4 2019 | $14,467,000 | +47.0% | 733,248 | +28.1% | 0.00% | 0.0% |
| Q3 2019 | $9,843,000 | -61.8% | 572,243 | -60.7% | 0.00% | -57.1% |
| Q2 2019 | $25,743,000 | -2.1% | 1,454,409 | +12.7% | 0.01% | 0.0% |
| Q1 2019 | $26,294,000 | +3914.4% | 1,290,837 | +3216.3% | 0.01% | – |
| Q4 2018 | $655,000 | – | 38,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |